Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
We report a case of toxic epidermal necrolysis who was successfully treated with intravenous immunoglobin and granulocyte colony-stimulating factor. He had poor prognostic factors such as extensive epidermal loss, neutropenia, acute respiratory distress syndrome and candida sepsis, but nonetheless made a complete recovery.
Kalyoncu
Mukaddes
M
Department of Pediatrics and Dermatology, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey. muratcak@hotmail.com
Cimsit
Gulseren
G
Cakir
Murat
M
Okten
Aysenur
A
D002675:Child, Preschool; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim